Cochrane COVID-19 Study Register
Study record
NCT05074420First Published: 2021 Oct 12Updated Date: 2021 Oct 12

A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients From 1 Year to Less Than 18 Years Old Hospitalized With COVID-19

  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Single Arm/Controlled Before After
  1. Intervention Assignment
  2. Not Applicable
Reference record

A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER-PEDS)

NCT05074420
Trial registry record
No Results
The purpose for this study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID -19) and to confirm the dose